5-Methyltetrahydrofolic acid stimulates endothelin-1 production in low density lipoprotein-treated human endothelial cells

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 3, 2007, Pages 188-194

  Ronco, Ana Maria ^a   Llanos, Miguel ^a   Tamayo, Daniela ^a   Hirsch, Sandra ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Endothelial cells; Endothelin; Folate; LDL; Vitamins

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5-METHYLTETRAHYDROFOLATE; COPPER; CYANOCOBALAMIN; ENDOTHELIN 1; FOLIC ACID; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TETRAHYDROFOLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; HUMAN; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

CELLS, CULTURED; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIN-1; FOLIC ACID; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; NITRIC OXIDE; OXIDATIVE STRESS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; TETRAHYDROFOLATES; VITAMIN B 12;

EID: 33947111008     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.12.005     Document Type: Article

References (48)

1. Verhaar M.C., Stroes E., and Rabelink T.J. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol 22 (2002) 6-13
2. Pena A.S., Wiltshire E., Gent R., Hirte C., and Couper J. Folic acid improves endothelial function in children and adolescents with type1diabetes. J Pediatr 144 (2004) 500-504
3. Paradisi G., Cucinelli F., Mele M.C., Barini A., Lanzone A., and Caruso A. Endothelial function in post-menopausal women: effect of folic acid supplementation. Hum Reprod 19 (2004) 1031-1035
4. Verhaar M.C., Wever R.M., Kastelein J.J., van Dam T., Koomans H.A., and Rabelink T.J. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 97 (1998) 237-241
5. Bellamy M., McDowell I.F., Ramsey M.W., Brownlee M., Newcombe R.G., and Lewis M.J. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur J Clin Invest 29 (1999) 659-662
6. Bennett-Richards K., Kattenhorn M., Donald A., Oakley G., Varghese Z., Rees L., et al. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure?. Circulation 105 (2002) 1810-1815
7. Schnyder G., Roffi M., Pin R., Flammer Y., Lange H., Eberli F.R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345 (2001) 1593-1600
8. Lange H., Suryapranata H., De Luca G., Borner C., Dille J., Kallmayer K., et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 350 (2004) 2673-2678
9. Olszewski A.J., and McCully K. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic Biol Med 14 (1993) 683-693
10. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., and Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (1997) 230-236
11. Wilmink H.W., Stroes E.S., Erkelens W.D., Gerritsen W.B., Wever R., Banga J.D., et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 20 (2000) 185-188
12. Doshi S.N., McDowell I.F., Moat S.J., Lang D., Newcombe R.G., Kredan M.B., et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?. Arterioscler Thromb Vasc Biol 21 (2001) 1196-1202
13. Wiltshire E.J., Gent R., Hirte C., Pena A., Thomas D.W., and Couper J.J. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 51 (2002) 2282-2286
14. Hirsch S., Ronco A.M., Vasquez M., de la Maza M.P., Garrido A., Barrera G., et al. Hyperhomocysteinemia in healthy young men and elderly men with normal serum folate concentration is not associated with poor vascular reactivity or oxidative stress. J Nutr 134 (2004) 1832-1835
15. Stroes E.S., van Faassen E.E., Yo M., Martasek P., Boer P., Govers R., et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 86 (2000) 1129-1134
16. Ronco A.M., Garrido A., Llanos M.N., Guerrero-Bosagna C., Tamayo D., and Hirsch S. Effect of homocysteine, folates and cobalamin on endothelial cell and copper-induced LDL oxidation. Lipids 40 (2005) 259-264
17. Havel R.J., Eder H.A., and Bradgon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34 (1955) 1345-1352
18. Terramani T.T., Eton D., Bui P.A., Wang Y., Weaver F.A., and Yu H. Human macrovascular endothelial cells: optimization of culture conditions. In Vitro Cell Dev Biol Anim 36 (2000) 125-132
19. Lapenna D., Ciofani G., Pierdomenico S.D., Giamberardino M.A., and Cuccurullo F. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 31 (2001) 331-335
20. Demuth K., Atger V., Borderie D., Benoit M.O., Sauvaget D., Lotersztajn S., et al. Homocysteine decreases endothelin-1 production by cultured human endothelial cells. Eur J Biochem 263 (1999) 367-376
21. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., and Currie M.G. A fluorimetric assay for the measurement of nitrite in biological samples. Anal Biochem 214 (1993) 11-16
22. Sparrow C.P., and Olszewski A.J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metals ions. J Lipid Res 3 (1993) 1219-1228
23. Gonzalez-Timon B., Gonzalez-Muñoz M., Zaragoza C., Lamas S., and Melian E.M. Native and oxidized low density lipoproteins oppositely modulate the effects of insulin-like growth factor I on VSMC. Cardiovasc Res 61 (2004) 247-255
24. Boulanger C.M., Tanner F.C., Bea M.L., Hahn A.W., Werner A., and Luscher T.F. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 70 (1992) 1191-1197
25. Horio T., Kohno M., Yasunari K., Murakawa K., Yokokawa K., Ikeda M., et al. Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured endothelial cells. Atherosclerosis 101 (1993) 185-190
26. Martin-Nizard F., Sqalli-Houssaini H., Walters-Laporte E., Boullier A., Fruchart J.C., and Duriez P. Oxidized high-density lipoproteins modulate endothelin secretion by adult bovine aortic endothelial cells. J Cardiovasc Risk 2 (1995) 263-267
27. Achmad T.H., Winterscheidt A., Lindermann C., and Rao G.S. Oxidized low density lipoprotein acts on endothelial cells in culture to enhance endothelin secretion and monocyte migration. Methods Find Exp Clin Pharmacol 19 (1997) 153-159
28. Martin-Nizard F., Furman C., Delerive P., Kandoussi A., Fruchart J.C., Staels B., et al. Peroxisome proliferators-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells. J Cardiovasc Pharmacol 40 (2002) 822-831
29. Niemann B., Rohrbach S., Catar R.A., Muller G., Barton M., and Morawietz H. Native and oxidized low-density lipoprotein stimulate endothelin-converting enzyme-1 expression in human endothelial cells. Biochem Biophys Res Commun 334 (2005) 747-753
30. Jougasaki M., Kugiyama K., Saito Y., Nakao K., Imura H., and Yasue H. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ Res 71 (1992) 614-619
31. He Y., Kwan W.C., and Steinbrecher U.P. Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages. Atherosclerosis 119 (1996) 107-118
32. Zhao R.Z., Chen X., Yao Q., and Chen C. TNF-alpha induces interleukin-8 and endothelin-1 expression in human endothelial cells with different redox pathways. Biochem Biophys Res Commun 327 (2005) 985-992
33. Ruef J., Moser M., Kubler W., and Bode C. Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol 10 (2001) 311-315
34. Kaehler J., Sill B., Koester R., Mittmann C., Orzechowski H.D., Muenzel T., et al. Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci (Lond) 103 Suppl. 48 (2002) 176S-178S
35. Michael J.R., Markewitz B.A., and Kohan D.E. Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells. Am J Physiol 273 (1997) L768-L774
36. Saito T., Itoh H., Chun T., Igaki T., Mori Y., Yamashita J., et al. Oxidative stress suppresses the endothelial secretion of endothelin. J Cardiovasc Pharmacol 31 Suppl. 1 (1998) S345-S347
37. Masatsugu K., Itoh H., Chun T.H., Saito T., Yamashita J., Doi K., et al. Shear stress attenuates endothelin and endothelin-converting enzyme expression through oxidative stress. Regul Pept 111 (2003) 13-19
38. Marsen T.A., Simonson M.S., and Dunn M.J. Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ Res 76 (1995) 987-995
39. Giardina J.B., Tanner D.J., and Khalil R.A. Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of protein kinase C isoforms alpha and epsilon. Hypertension 37 (2000) 561-568
40. Lee M.E., Dhadly M.S., Temizer D.H., Clifford J.A., Yoshizumi M., and Quertermous T. Regulation of endothelin-1 gene expression by Fos and Jun. J Biol Chem 266 (1991) 19034-19039
41. Kawama M., Lee M.E., Quertermous E.E., and Quertermous T. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol 15 (1995) 4225-4231
42. Delerive P., Furman C., Teissier E., Fruchart J., Duriez P., and Staels B. Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett 471 (2000) 34-38
43. Han K.H., Chang M.K., Boullier A., Green S.R., Li A., Glass C.K., et al. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferators-activated receptor gamma. J Clin Invest 106 (2000) 793-802
44. Nagy L., Tontonoz P., Alvarez J.G., Chen H., and Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR gamma. Cell 93 (1998) 229-240
45. Garin M.C., Kalix B., Morabia A., and James R.W. Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 90 (2005) 2264-2269
46. Gottsater A., Forsblad J., Mattiasson I., and Lindgarde F. Decreasing plasma endothelin-1 and unchanged plasma neopterin during folate supplementation in hyperhomocysteinemia. Int Angiol 21 (2002) 158-164
47. B receptor in endothelial cells. J Biol Chem 269 (1994) 21778-21785
48. Boulanger C., and Luscher T. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85 (1991) 587-590